Unclaimed brand
Beactica Therapeutics is a precision medicine company developing novel small molecule therapeutics to treat life-threatening diseases with significant unmet clinical need.
Liking this brand profile? Share this page


Hex Code
Color name
RGB
HSL
CMYK
#C2CD23
Key Lime Pie
194, 205, 35
64, 71, 47
5, 0, 83, 20
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#4C4D4F
Abbey
76, 77, 79
220, 2, 30
4, 3, 0, 69
Beactica Therapeutics is an innovative drug development brand that aims to enhance lives through groundbreaking therapeutics. Their vision is to transform the prospects for patients suffering from life-threatening cancers by creating breakthrough treatments. They are dedicated to developing novel therapeutics that will benefit cancer patients worldwide, bringing hope to those patients and their families.
Beactica's scientific breakthroughs have impressed giants in the pharmaceutical industry, and they have successfully selected and targeted key disease proteins vital for cancer treatment. The brand's name, Beactica, is recognized as a symbol of outstanding innovation and scientific excellence. Beactica's mission is to address genetically defined cancers with high unmet medical needs by targeting synthetically lethal disease proteins using allosteric modulators and targeted protein degraders (PROTACs).
They adopt core values of integrity, excellence, innovation, and diligence, which serve as the foundation of their work. By combining their creative outlook, world-class science, and collaboration, Beactica is making a difference where it truly matters. Stay updated with their latest news and developments by signing up for the Beactica newsletter and following their social media accounts
Company type
Privately Held
Year founded
2006
Company size
11-50 employees